← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Opus Genetics IRD $337M	34	-3	-8%	$10.8M
77	77 Solid Biosciences SLDB $615M	34	-24	-41%	$85.3M
78	BLCM 78 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	33	+5	+18%	$1.23M
79	GRCL 79 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	33	0	0%	$70M
80	80 Pluri PLUR $11.9M	33	-3	-8%	$655K
81	PTE 81 DELISTED PolarityTE, Inc. Common Stock PTE	32	+5	+19%	$449K
82	SGTX 82 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	32	-1	-3%	$6.12M
83	83 Capricor Therapeutics CAPR $423M	30	-1	-3%	$9.94M
84	84 PharmaCyte Biotech PMCB $3.84M	30	-1	-3%	$9.93M
85	85 TScan Therapeutics TCRX $16.2M	28	+2	+8%	$14.8M
86	86 ProKidney PROK $305M	27	+9	+50%	$216M
87	87 Senti Biosciences Holdings SNTI $8.14M	26	+3	+13%	$16.6M
88	88 BioCardia BCDA $14.2M	25	+2	+9%	$4.87M
89	89 Benitec Biopharma BNTC $295M	25	0	0%	$2.09M
90	90 DELISTED Scorpius Holdings, Inc. SCPX	24	+1	+4%	$2M
91	ACHL 91 DELISTED Achilles Therapeutics ACHL	23	-5	-18%	$19.5M
92	92 Calidi Biotherapeutics CLDI $2.25M	23	+3	+15%	$39.6M
93	93 Candel Therapeutics CADL $682M	21	-4	-16%	$9.7M
94	94 Enlivex Ltd ENLV $4.46M	21	+3	+17%	$1.32M
95	95 Imunon IMNN $5.95M	21	0	0%	$573K
96	96 DELISTED Orgenesis Inc. Common Stock ORGS	19	-3	-14%	$3.02M
97	97 Creative Medical Technology CELZ $6.21M	18	+1	+6%	$157K
98	98 Genprex GNPX $1.88M	18	-2	-10%	$5.85M
99	99 Immix Biopharma IMMX $720M	18	+6	+50%	$1.01M
100	FRLN 100 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	17	+3	+21%	$18.2M